Pedro A. Torres‐Saavedra

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Evolutionary Action Score of TP53 Analysis in Pathologically High-Risk Human Papillomavirus-Negative Head and Neck Cancer From a Phase 2 Clinical Trial: NRG Oncology Radiation Therapy Oncology Group 0234”.

Evolutionary Action Score of TP53 Analysis in Pathologically High-Risk Human Papillomavirus-Negative Head and Neck Cancer From a Phase 2 Clinical Trial: NRG Oncology Radiation Therapy Oncology Group 0234

Advances in Radiation Oncology(2022)10.1016/j.adro.2022.100989

N/A

0.269DataRank · unranked

5 citations

Pedro A. Torres‐Saavedra, Natalie L. Silver, Paul M. Harari, Merrill S. Kies, D.I. Rosenthal +15 more

Association of plasma tumor tissue modified viral HPV DNA (TTMV) with tumor burden, treatment type, and outcome: A translational analysis from NRG-HN002.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.6006

N/A

0DataRank · unranked

12 citations

Pedro A. Torres‐Saavedra, Charlotte Kuperwasser, Sunil Kumar, Piyush B. Gupta, Patrick K. Ha +12 more

NRG Oncology HN006: Randomized phase II/III trial of sentinel lymph node biopsy versus elective neck dissection for early-stage oral cavity cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.tps6093

N/A

0DataRank · unranked

11 citations

Pedro A. Torres‐Saavedra, Neal Dunlap, Beth M. Beadle, Steven S. Chang, Rathan M. Subramaniam +13 more

Surrogate endpoints in clinical trials of p16-positive squamous cell carcinoma of the oropharynx: an individual patient data meta-analysis

The Lancet Oncology(2024)10.1016/s1470-2045(24)00016-0

N/A

0DataRank · unranked

9 citations

Emily Morris, Krithika Suresh, Phuc Félix Nguyen‐Tan, David I. Rosenthal, Maura L. Gillison +18 more

Challenges and opportunities for early phase clinical trials of novel drug–radiotherapy combinations: recommendations from NRG Oncology, the American Society for Radiation Oncology (ASTRO), the American College of Radiology (ACR), the Sarah Cannon Research Institute, and the American College of Radiation Oncology (ACRO)

The Lancet Oncology(2024)10.1016/s1470-2045(24)00264-x

N/A

0DataRank · unranked

6 citations

Siddharth Sheth, Salma K. Jabbour, Krishnan R. Patel, Randall J. Kimple, Terence M. Williams +9 more

Best practices and pragmatic approaches for patient-reported outcomes and quality of life measures in cancer clinical trials

JNCI Monographs(2025)10.1093/jncimonographs/lgae047

N/A

0DataRank · unranked

7 citations

Pedro A. Torres‐Saavedra, Eva Culakova, Heather Gunn, Minji K. Lee, Fenghai Duan +5 more

NRG-DT001 phase Ib trial of neoadjuvant navtemadlin (previously AMG232 and KRT232) concurrent with preoperative radiotherapy in wild-type p53 soft tissue sarcoma of the extremity and body wall.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.11521

N/A

0DataRank · unranked

2 citations

Pedro A. Torres‐Saavedra, Brian Andrew Van Tine, David G. Kirsch, Michelle A. Rudek, Paul E. Wakely +13 more